Manufacturer record
Talwar Pharma: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
2 batches manufactured by Talwar Pharma (Uttarakhand) were declared Not of Standard Quality between February 2023 and November 2023. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: RPC-230704, Rabeprazole Sodium (Enteric Coated) & Domperidone (Sustained Release) Capsules (Rabetal- DSR) (exp Jun 2025). CDL Kolkata (CDSCO lab) found it not of standard quality: Dissolution. Listed in the November 2023 alert.
Records by type
2 records linked to Talwar Pharma in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Rabeprazole Sodium (Enteric Coated) & Domperidone (Sustained Release) Capsules (Rabetal- DSR) | Batch RPC-230704Mfg Jul 2023 · Exp Jun 2025 | DissolutionDissolution | CDL KolkataCDSCO lab | Nov 2023 |
| OMICERR -20 (Omeprazole Capsules IP) | Batch TPC-220263Mfg Feb 2022 · Exp Jan 2024 | Dissolution (Acid Stage) and Loss on DryingDissolution | RDTL GuwahatiCDSCO lab | Feb 2023 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.